More than half of U.S. adults with uncontrolled hypertension are unaware they have hypertension in the first place, according to a recent study in JAMA Network Open. Furthermore, more than two-thirds ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Findings showed treatment with lorundrostat resulted in statistically significant reductions in systolic blood pressure compared with placebo. Topline data were announced from a phase 3 trial ...

Medically reviewed by Jeffrey S. Lander, MD Key Takeaways High blood pressure can cause heart disease by damaging your blood ...

Two new studies found promising treatments for uncontrolled high blood pressure and a “stealth” cholesterol called Lipoprotein (a) that was previously believed to be untreatable. NBC’s Dr. Natalie ...

Discover crucial insights on hypertension in India, its prevalence, risk factors, and the urgent need for effective ...

Mineralys Therapeutics, Inc. announced that it will present data from its Phase 2 Advance-HTN trial on lorundrostat, a novel aldosterone synthase inhibitor for treating uncontrolled and resistant ...

The FDA has granted Breakthrough Device Designation to Orchestra BioMed's Atrioventricular Interval Modulation (AVIM) therapy, aimed at treating patients with uncontrolled hypertension who are at ...

Among individuals with cardiovascular disease or high cardiovascular risk and uncontrolled hypertension on multiple anti-hypertensive agents, a single subcutaneous dose of zilebesiran 300 mg led to a ...

High blood pressure affects about 45% of U.S. adults. In the 1970s, only about 50% of patients were aware of their hypertension. Today, 54% are aware of their high blood pressure, 40% are actively ...

The World Health Organization (WHO) today released its second Global hypertension report, showing that 1.4 billion people lived with hypertension in 2024, yet just over one in five have it under ...